|
ASB1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.86739512741951E-13 |
| Normal-vs-Stage2 |
2.33660000004132E-06 |
| Normal-vs-Stage3 |
6.38370467598293E-11 |
| Normal-vs-Stage4 |
2.78532752417959E-12 |
| Stage1-vs-Stage2 |
8.192000E-01 |
| Stage1-vs-Stage3 |
4.073400E-01 |
| Stage1-vs-Stage4 |
1.493950E-02 |
| Stage2-vs-Stage3 |
5.136200E-01 |
| Stage2-vs-Stage4 |
1.051200E-01 |
| Stage3-vs-Stage4 |
1.321630E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.55111512312578E-16 |
| Normal-vs-AfricanAmerican |
1.515940E-03 |
| Normal-vs-Asian |
1.53920000078855E-08 |
| Caucasian-vs-AfricanAmerican |
9.784100E-02 |
| Caucasian-vs-Asian |
6.833800E-01 |
| AfricanAmerican-vs-Asian |
2.240600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.74427139398858E-12 |
| Normal-vs-Female |
1.78512760129479E-12 |
| Male-vs-Female |
1.695680E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.40052422384451E-12 |
| Normal-vs-Age(41-60Yrs) |
2.61013433089374E-12 |
| Normal-vs-Age(61-80Yrs) |
2.7787772083343E-12 |
| Normal-vs-Age(81-100Yrs) |
4.982700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.227600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.674000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.152600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.311600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.976800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.511800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.93866000000043E-05 |
| Classical-VS-Follicular |
7.062500E-03 |
| Classical-VS-Other |
1.751990E-01 |
| Classical-VS-Normal |
2.44204656496549E-12 |
| Tall-VS-Follicular |
2.263200E-01 |
| Tall-VS-Other |
9.404400E-01 |
| Tall-VS-Normal |
1.76958447895004E-12 |
| Follicular-VS-Other |
7.054400E-01 |
| Follicular-VS-Normal |
8.33655366960784E-12 |
| Other-VS-Normal |
5.770600E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.67372798848464E-13 |
| Normal-vs-N1 |
5.3197446447939E-12 |
| N0-vs-N1 |
7.452500E-02 |
|
|
